188 related articles for article (PubMed ID: 30417376)
1. Impaired DNA double-strand breaks repair by kinesin family member 4A inhibition renders human H1299 non-small-cell lung cancer cells sensitive to cisplatin.
Wan Q; Shen Y; Zhao H; Wang B; Zhao L; Zhang Y; Bu X; Wan M; Shen C
J Cell Physiol; 2019 Jul; 234(7):10360-10371. PubMed ID: 30417376
[TBL] [Abstract][Full Text] [Related]
2. PARP inhibition selectively increases sensitivity to cisplatin in ERCC1-low non-small cell lung cancer cells.
Cheng H; Zhang Z; Borczuk A; Powell CA; Balajee AS; Lieberman HB; Halmos B
Carcinogenesis; 2013 Apr; 34(4):739-49. PubMed ID: 23275151
[TBL] [Abstract][Full Text] [Related]
3. A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer.
Postel-Vinay S; Bajrami I; Friboulet L; Elliott R; Fontebasso Y; Dorvault N; Olaussen KA; André F; Soria JC; Lord CJ; Ashworth A
Oncogene; 2013 Nov; 32(47):5377-87. PubMed ID: 23934192
[TBL] [Abstract][Full Text] [Related]
4. A novel role of the chromokinesin Kif4A in DNA damage response.
Wu G; Zhou L; Khidr L; Guo XE; Kim W; Lee YM; Krasieva T; Chen PL
Cell Cycle; 2008 Jul; 7(13):2013-20. PubMed ID: 18604178
[TBL] [Abstract][Full Text] [Related]
5. A trifunctional Pt(II) complex alleviates the NHEJ/HR-related DSBs repairs to evade cisplatin-resistance in NSCLC.
Wang X; Wang Y; Gou S; Chen F
Bioorg Chem; 2020 Nov; 104():104210. PubMed ID: 32920356
[TBL] [Abstract][Full Text] [Related]
6. Co-inhibition of Pol η and ATR sensitizes cisplatin-resistant non-small cell lung cancer cells to cisplatin by impeding DNA damage repair.
Li XQ; Ren J; Chen P; Chen YJ; Wu M; Wu Y; Chen K; Li J
Acta Pharmacol Sin; 2018 Aug; 39(8):1359-1372. PubMed ID: 29849128
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of REV3 synergizes with ATR inhibition to promote apoptosis induced by cisplatin in lung cancer cells.
Jiang HG; Chen P; Su JY; Wu M; Qian H; Wang Y; Li J
J Cell Physiol; 2017 Dec; 232(12):3433-3443. PubMed ID: 28075014
[TBL] [Abstract][Full Text] [Related]
8. RAD52 motif‑containing protein 1 promotes non‑small cell lung cancer cell proliferation and survival via cell cycle regulation.
Xu G; Du J; Wang F; Zhang F; Hu R; Sun D; Shen J
Oncol Rep; 2018 Aug; 40(2):833-840. PubMed ID: 29845285
[TBL] [Abstract][Full Text] [Related]
9. PARP1 impact on DNA repair of platinum adducts: preclinical and clinical read-outs.
Olaussen KA; Adam J; Vanhecke E; Vielh P; Pirker R; Friboulet L; Popper H; Robin A; Commo F; Thomale J; Kayitalire L; Filipits M; Le Chevalier T; André F; Brambilla E; Soria JC
Lung Cancer; 2013 May; 80(2):216-22. PubMed ID: 23410825
[TBL] [Abstract][Full Text] [Related]
10. Detection of impaired homologous recombination repair in NSCLC cells and tissues.
Birkelbach M; Ferraiolo N; Gheorghiu L; Pfäffle HN; Daly B; Ebright MI; Spencer C; O'Hara C; Whetstine JR; Benes CH; Sequist LV; Zou L; Dahm-Daphi J; Kachnic LA; Willers H
J Thorac Oncol; 2013 Mar; 8(3):279-86. PubMed ID: 23399959
[TBL] [Abstract][Full Text] [Related]
11. Olaparib modulates DNA repair efficiency, sensitizes cervical cancer cells to cisplatin and exhibits anti-metastatic property.
Prasad CB; Prasad SB; Yadav SS; Pandey LK; Singh S; Pradhan S; Narayan G
Sci Rep; 2017 Oct; 7(1):12876. PubMed ID: 28993682
[TBL] [Abstract][Full Text] [Related]
12. DNA Damage-Response Pathway Heterogeneity of Human Lung Cancer A549 and H1299 Cells Determines Sensitivity to 8-Chloro-Adenosine.
Yang SY; Li Y; An GS; Ni JH; Jia HT; Li SY
Int J Mol Sci; 2018 May; 19(6):. PubMed ID: 29843366
[TBL] [Abstract][Full Text] [Related]
13. Enhancement of Radiosensitivity by Eurycomalactone in Human NSCLC Cells Through G₂/M Cell Cycle Arrest and Delayed DNA Double-Strand Break Repair.
Dukaew N; Konishi T; Chairatvit K; Autsavapromporn N; Soonthornchareonnon N; Wongnoppavich A
Oncol Res; 2020 Mar; 28(2):161-175. PubMed ID: 31727206
[TBL] [Abstract][Full Text] [Related]
14. Kinesin Kif2C in regulation of DNA double strand break dynamics and repair.
Zhu S; Paydar M; Wang F; Li Y; Wang L; Barrette B; Bessho T; Kwok BH; Peng A
Elife; 2020 Jan; 9():. PubMed ID: 31951198
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor-1 attenuates cisplatin-induced gammaH2AX formation and DNA double-strand breaks repair pathway in non-small cell lung cancer.
Jeon JH; Kim SK; Kim HJ; Chang J; Ahn CM; Chang YS
Cancer Lett; 2008 Dec; 272(2):232-41. PubMed ID: 18762365
[TBL] [Abstract][Full Text] [Related]
16. Involvement of homologous recombination in the synergism between cisplatin and poly (ADP-ribose) polymerase inhibition.
Sakogawa K; Aoki Y; Misumi K; Hamai Y; Emi M; Hihara J; Shi L; Kono K; Horikoshi Y; Sun J; Ikura T; Okada M; Tashiro S
Cancer Sci; 2013 Dec; 104(12):1593-9. PubMed ID: 24033642
[TBL] [Abstract][Full Text] [Related]
17. Cisplatin-mediated radiosensitization of non-small cell lung cancer cells is stimulated by ATM inhibition.
Toulany M; Mihatsch J; Holler M; Chaachouay H; Rodemann HP
Radiother Oncol; 2014 May; 111(2):228-36. PubMed ID: 24857596
[TBL] [Abstract][Full Text] [Related]
18. Kinesin KIF4A is associated with chemotherapeutic drug resistance by regulating intracellular trafficking of lung resistance-related protein.
Pan LN; Zhang Y; Zhu CJ; Dong ZX
J Zhejiang Univ Sci B; 2017 Dec.; 18(12):1046-1054. PubMed ID: 29204984
[TBL] [Abstract][Full Text] [Related]
19. Oxidative DNA double strand breaks and autophagy in the antitumor effect of sterically hindered platinum(II) complexes in NSCLCs.
Chen F; Wang X; Jin X; Zhao J; Gou S
Oncotarget; 2017 May; 8(19):30933-30955. PubMed ID: 28427237
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of homologous recombination in human cells by targeting RAD51 recombinase.
Huang F; Mazina OM; Zentner IJ; Cocklin S; Mazin AV
J Med Chem; 2012 Apr; 55(7):3011-20. PubMed ID: 22380680
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]